Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA019493 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA019493, RRID:AB_1855457
- Product name
- Anti-LCP1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human LCP1, Gene description: lymphocyte cytosolic protein 1 (L-plastin), Alternative Gene Names: CP64, L-PLASTIN, LC64P, PLS2, Validated applications: ICC, IHC, WB, Uniprot ID: P13796, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.5 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas.
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Levels of human proteins in plasma associated with acute paediatric malaria.
Affinity Proteomics Reveals Elevated Muscle Proteins in Plasma of Children with Cerebral Malaria
Pankova V, Krasny L, Kerrison W, Tam YB, Chadha M, Burns J, Wilding CP, Chen L, Chowdhury A, Perkins E, Lee ATJ, Howell L, Guljar N, Sisley K, Fisher C, Chudasama P, Thway K, Jones RL, Huang PH
Clinical cancer research : an official journal of the American Association for Cancer Research 2024 Aug 1;30(15):3229-3242
Clinical cancer research : an official journal of the American Association for Cancer Research 2024 Aug 1;30(15):3229-3242
Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y, Okubo M, Eizuka K, Ando T, Nobuchi T, Kawasaki K, Saito T, Iyoda M, Nakashima D, Kasamatsu A, Tanzawa H
Scientific reports 2021 Mar 15;11(1):5897
Scientific reports 2021 Mar 15;11(1):5897
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
Signorelli M, Ayoglu B, Johansson C, Lochmüller H, Straub V, Muntoni F, Niks E, Tsonaka R, Persson A, Aartsma‐Rus A, Nilsson P, Al‐Khalili Szigyarto C, Spitali P
Journal of Cachexia, Sarcopenia and Muscle 2019;11(2):505-517
Journal of Cachexia, Sarcopenia and Muscle 2019;11(2):505-517
Levels of human proteins in plasma associated with acute paediatric malaria.
Reuterswärd P, Bergström S, Orikiiriza J, Lindquist E, Bergström S, Andersson Svahn H, Ayoglu B, Uhlén M, Wahlgren M, Normark J, Ribacke U, Nilsson P
Malaria journal 2018 Nov 15;17(1):426
Malaria journal 2018 Nov 15;17(1):426
Affinity Proteomics Reveals Elevated Muscle Proteins in Plasma of Children with Cerebral Malaria
Kim K, Bachmann J, Burté F, Pramana S, Conte I, Brown B, Orimadegun A, Ajetunmobi W, Afolabi N, Akinkunmi F, Omokhodion S, Akinbami F, Shokunbi W, Kampf C, Pawitan Y, Uhlén M, Sodeinde O, Schwenk J, Wahlgren M, Fernandez-Reyes D, Nilsson P
PLoS Pathogens 2014;10(4):e1004038
PLoS Pathogens 2014;10(4):e1004038
No comments: Submit comment
No validations: Submit validation data